Pharmafile Logo

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our “Top 10 Tips for Optimizing Asynchronous Virtual Meetings”.

- PMLiVE

Unlock the potential of asynchronous virtual meetings with our first essential tip. Discover the art of asking your advisors and stakeholders the right questions via the Impetus InSite Platform® to drive meaningful and insightful discussions.

1. Ask Open-Ended, Indirect Questions
Learn how to elevate your virtual meetings by avoiding yes/no questions. Instead, engage participants with open-ended inquiries that encourage descriptive answers. We’ll share how using words like “describe,” “explain,” and “compare” can significantly enhance dialogue depth. Also, get insights on how posing indirect questions can help capture genuine perspectives by asking about colleagues’ or patients’ views rather than direct personal opinions.

This video is a quick guide to optimizing your asynchronous virtual meetings, offering a glimpse into effective communication strategies that foster comprehensive engagement.

For more insights into optimizing your virtual meetings and engaging effectively with your stakeholders, continue watching our series. Discover the full range of tips and how the Impetus InSite Platform® can transform your digital interactions by visiting our blog: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/

Connect with Impetus Digital for deeper engagement:
Explore our solutions: www.impetusdigital.com
Schedule a conversation: https://meetwithimpetus.com/

Stay updated via our social channels:
LinkedIn: https://linkedin.com/company/impetus-digital
Twitter: https://twitter.com/impetus_digital
Facebook: https://facebook.com/ImpetusDigital.fb
Check out our podcast for more insights: https://impetusdigital.com/podcast/

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...

Navigating the Nuances of Europe’s MedTech Industry

Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and...

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with...

Traversing the Medtech Regulatory Landscape in the Interest of Patients

Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...

Scanning for Health Indicators and Risks Through Your Smartphone

Vlado Bosanac, Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging, dives into the implications of increased integration of tech and data into daily life for the...

Virtual MSL/Sales training programs and events

Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events

Top 10 Benefits of Virtual Advisory Boards

As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish...

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...

The Future of MedTech: Streamlined Clinical Data Collection & Management

Jón Ingi Bergsteinsson, Co-founder & CCO at SMART-TRIAL, explores the barriers to, and benefits of, digitalization of clinical operations and trials in the MedTech industry, plus much more!

Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?

With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and...